S-1/A: Bioxytran Files Amendment to S-1 Registration Statement for Common Stock Offering

Bioxytran, Inc. files an amendment to its S-1 registration statement to include the opinion of legal counsel regarding the legality of issuing up to 18,000,000 shares of common stock.

Summary

• Bioxytran, Inc. has filed an amendment to its Form S-1 registration statement with the SEC.
• The amendment includes the opinion of Witherspoon Brajcich McPhee, PLLC, legal counsel, regarding the legality of the common stock offering.
• The company intends to offer a maximum of 18,000,000 shares of common stock.
• The offering is an indirect primary offering to TRITON FUNDS LP (TRITON), pursuant to a Closing Agreement.
• The company is registered in Nevada.
• David Platt, PhD, is the Chairman, President, and CEO of Bioxytran, Inc.

Sentiment

Score: 7

Explanation: The document is a standard regulatory filing, indicating progress towards a potential capital raise. The legal opinion supports the validity of the offering, which is generally positive. However, the actual success of the offering and its impact on the company's value remain to be seen.

Positives

• Legal counsel has provided an opinion that the company is duly organized and validly existing under Nevada law.
• Legal counsel has provided an opinion that the company has taken all requisite corporate action and all action required with respect to the authorization, issuance and sale of Common Stock issued pursuant to the Registration Statement.
• Legal counsel has provided an opinion that the up to 18,000,000 shares of Common Stock to be issued via an indirect primary offering to TRITON FUNDS LP (TRITON), pursuant to a Closing Agreement, once issued will be duly authorized, validly issued, fully paid and non-assessable.

Future Outlook

The company intends to commence the proposed sale to the public as soon as practicable after the Registration Statement is declared effective.

Industry Context

This filing is a standard step for companies seeking to raise capital through the public markets. The inclusion of a legal opinion is a routine requirement for SEC registration statements.

Stakeholder Impact

• Shareholders may experience dilution if the offering is completed.
• The company may have additional capital to fund its operations and growth.

Next Steps

• The SEC will review the registration statement.
• The company will proceed with the offering once the registration statement is declared effective.

Key Dates

Keywords

S-1, registration statement, common stock, offering, Bioxytran, securities, SEC, Triton Funds LP